NON-DISCLOSURE AGREEMENTNon-Disclosure Agreement • March 8th, 2024 • Column Group L P • Pharmaceutical preparations • California
This Non-Disclosure Agreement (“Agreement”), effective as of October 31, 2023 (“Effective Date”), is entered into by and between NGM Biopharmaceuticals, Inc., a Delaware corporation (“Discloser”) and The Column Group LLC (“Recipient”). Under this Agreement, Discloser may furnish certain of its confidential information to Counterparty in connection with the Counterparty’s evaluation of Discloser (“Purpose”) upon the terms and conditions set forth below.
JOINDER AGREEMENT Dated: March 6, 2024Joinder Agreement • March 8th, 2024 • Column Group L P • Pharmaceutical preparations • Delaware
This Joinder Agreement (“Joinder Agreement”) is executed by the undersigned (“Additional Holders”), pursuant to the terms of the Rollover Agreement, dated as of February 25, 2024, a copy of which is attached hereto and is incorporated herein by reference (the “Rollover Agreement”). By the execution of this Joinder Agreement, each Additional Holder agrees as follows:
